These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion. Berger WE; Schenkel EJ; Mansfield LE; Ann Allergy Asthma Immunol; 2002 Nov; 89(5):485-91. PubMed ID: 12452207 [TBL] [Abstract][Full Text] [Related]
4. Desloratadine for chronic idiopathic urticaria: a review of clinical efficacy. DuBuske L Am J Clin Dermatol; 2007; 8(5):271-83. PubMed ID: 17902729 [TBL] [Abstract][Full Text] [Related]
5. Desloratadine: an update of its efficacy in the management of allergic disorders. Murdoch D; Goa KL; Keam SJ Drugs; 2003; 63(19):2051-77. PubMed ID: 12962522 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic points of intervention and clinical implications: role of desloratadine. Bachert C Allergy; 2002; 57 Suppl 75():13-8. PubMed ID: 12492724 [TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of desloratadine in subjects with seasonal allergic rhinitis or chronic urticaria: results of four postmarketing surveillance studies. Bachert C; Maurer M Clin Drug Investig; 2010; 30(2):109-22. PubMed ID: 20067329 [TBL] [Abstract][Full Text] [Related]
8. Desloratadine: a nonsedating antihistamine. Limon L; Kockler DR Ann Pharmacother; 2003 Feb; 37(2):237-46; quiz 313-6. PubMed ID: 12549956 [TBL] [Abstract][Full Text] [Related]
9. Desloratadine activity in concurrent seasonal allergic rhinitis and asthma. Baena-Cagnani CE Allergy; 2001; 56 Suppl 65():21-7. PubMed ID: 11243501 [TBL] [Abstract][Full Text] [Related]
10. [The place of new antihistamines in allergy management. Apropos of desloratadine]. Sabbah A Allerg Immunol (Paris); 2002 Dec; 34(10):377-83. PubMed ID: 12575624 [TBL] [Abstract][Full Text] [Related]
11. Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit. Horak F; Stübner UP; Zieglmayer R; Harris AG J Allergy Clin Immunol; 2002 Jun; 109(6):956-61. PubMed ID: 12063524 [TBL] [Abstract][Full Text] [Related]
12. Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. Ring J; Hein R; Gauger A; Bronsky E; Miller B Int J Dermatol; 2001 Jan; 40(1):72-6. PubMed ID: 11277962 [TBL] [Abstract][Full Text] [Related]
13. Review of desloratadine for the treatment of allergic rhinitis, chronic idiopathic urticaria and allergic inflammatory disorders. DuBuske LM Expert Opin Pharmacother; 2005 Nov; 6(14):2511-23. PubMed ID: 16259582 [TBL] [Abstract][Full Text] [Related]
14. The safety and efficacy of desloratadine for the management of allergic disease. Berger WE Drug Saf; 2005; 28(12):1101-18. PubMed ID: 16329713 [TBL] [Abstract][Full Text] [Related]